City
Epaper

Two indigenous candidate COVID-19 vaccines get DCGI nod to start early phase human trials

By ANI | Updated: July 14, 2020 19:35 IST

Two indigenous candidate vaccines for COVID-19 have got DCGI clearance to start early phase human trials in the country, the Indian Council of Medical Research (ICMR) said on Tuesday.

Open in App

Two indigenous candidate vaccines for COVID-19 have got DCGI clearance to start early phase human trials in the country, the Indian Council of Medical Research (ICMR) said on Tuesday.

"There are two Indian indigenous candidate vaccines. They have undergone successful toxicity studies in rats, mice and rabbits. The data was submitted to DCGI following which both these got clearance to start early phase human trials early this month," said Dr Balram Bhargava, DG-ICMR at a daily press briefing here.

"They have got their sites ready and they are doing their clinical study on approximately a thousand volunteers each at different sites," he added.

Bhargava said that experiments for the two vaccines, among others, are also being done at NIV, Pune and spoke about the various programmes being carried out to develop a vaccine globally.

"Recently, Russia has fast-tracked a vaccine which has been successful in the early phases and they have fast-tracked its development. The whole world has applauded it and congratulated Russia. China has also fast-tracked its vaccine programme and fast-tracked its studies with vaccines. The US has again fast-tracked two of its vaccine candidates and the UK is also looking at how it can fastrack the Oxford vaccine candidate," Bhargava said.

He added that India supplies over 60 per cent of the vaccines for various diseases to countries around the world and said that it makes India's role a key one in the race to prepare and supply a COVID-19 vaccine to the world.

"India is considered as the pharmacy of the world. 60 per cent of the drugs utilised in the US are of Indian origin. The other fact which is not well known is that 60 percent of vaccines supplied around the world are of Indian origin, so India is perceived and is well known for vaccine supply in the world," Bhargava said.

"Any vaccine produced in any party part of the world will ultimately have to be scaled up by India or by China. Because these are the two major vaccine producers of the world. Everyone who is trying to prepare a vaccine is in talks with India," he further said.

( With inputs from ANI )

Tags: puneOxfordIndian Council Of Medical ResearchIcmrBalram BhargavaIndia council of medical researchIndian council of medicalIndian council medical researchIndian council for medicalMumbai pune
Open in App

Related Stories

PunePune Cyber Fraud: Man Loses ₹2.5 Lakh After Falling for Fake RTO Penalty Scam

PunePune Cyber Fraud Alert: Two City Youths Cheated of Rs 51.16 Lakh Through Fake Stock Market, Online Task Scams

MaharashtraAjit Pawar on NCP’s Breakaway from Mahayuti for Local Body Polls, Says ‘We Have Always Fought Against Each Other, Nothing Different Here’

PunePune Tragedy: Son Finds Parents Dead After Returning from Night Shift in Kondhwa, Post-Mortem to Reveal Cause

Pune“There Were Never Issues Within Family”: Supriya Sule on Joining Hands With Ajit Pawar’s NCP in Pune Civic Polls

National Realted Stories

NationalBihar: Revenue officer caught red-handed while taking bribe in Gopalganj

NationalGujarat CM reviews wildlife care centre as ‘Karuna Abhiyan’ intensifies

NationalBengal: Three killed in firecracker factory explosion

NationalHM Shah unveils Rs 250-crore development push in Mansa, lays foundation for pharma academy in Ahmedabad

NationalPatna Police crack high-profile Aman Shukla murder case, three arrested